Cogent Biosciences
COGT
COGT
39 hedge funds and large institutions have $33.7M invested in Cogent Biosciences in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-14
Holders Change %
-26.42%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
5
Increased
7
Reduced
18
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$1.03M |
| 2 |
PP
2
Paloma Partners
Greenwich,
Connecticut
|
$227K |
| 3 |
3
Barclays
London,
United Kingdom
|
$152K |
| 4 |
4
Jane Street
New York
|
$132K |
| 5 |
5
Goldman Sachs
New York
|
$153K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| – | -$17K | -972 | Closed |
|
|
SO
52
STRS Ohio
Columbus,
Ohio
| – | -$4K | -250 | Closed |
|
53
New York State Common Retirement Fund
Albany,
New York
| – | -$2K | -125 | Closed |
|
|
AIP
54
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$1K | -69 | Closed |
|
|
CLOS
55
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | -$1K | -50 | Closed |
|